Yen-Po (Louis) Lee, MS yen-po-lee@uiowa.edu

Yen-Po holds two Masters degrees: Biomedical Imaging and Radiological Science at National Yang-Ming University in Taiwan and  Medical Physics at Columbia University in the US. His research experience and interest cross multiple fields, including molecular biology, radiobiology, FLASH therapy, and using programming to fix clinical issues or improve treatment quality. His clinical interests include proton therapy, MR-LINAC, and adaptive therapy.

Nicholas Carlson, MS nicholas-f-carlson@uiowa.edu

Nick earned his MS in Medical Physics from San Diego State University and BS in Physics from South Dakota State University attending both SDSU’s. He has radiobiology research experience through his development of a shippable biological tool for evaluating dose modifying factors such as proton and FLASH therapy. Nick’s clinical interest involves improving the therapeutic ratio by taking advantage of radiobiological responses for increased tumor control and limiting normal tissue toxicity using technologies such as MR-Linac adaptive radiotherapy. His hobbies outside of work include fishing, hiking, skiing/snowboarding, camping, scuba diving, and surfing.

Grace Hutchinson, MS grace-hutchinson@uiowa.edu

Grace Hutchinson earned her master’s degree in medical physics from the University of Minnesota and received her bachelor’s degree in applied physics from Bethel University. Her research is focused on creating dose response models for both chronic renal toxicity and hypothyroidism in pediatric bone marrow transplant conditioning regimens using total body irradiation. 

Jun Hsuang (Oscar) Jen, PhD junhsuang-jen@uiowa.edu

Jun Hsuang (Oscar) Jen received his master’s degree in medical physics from Columbia University and his bachelor’s degree in biomedical Imaging and radiological science from the National Yang- Ming University in Taiwan. His prior research experience revolved around radiomics, longitudinal tumor response tracking, and medical image analysis. Oscar’s clinical interest involves adaptive therapy, proton therapy, and optimizing the precision of radiotherapy.